home / stock / apri / apri quote
Last: | $ |
---|---|
Change Percent: | -2.87% |
Open: | $0.23 |
Close: | $0.22 |
High: | $0.23 |
Low: | $0.2069 |
Volume: | 1,101,864 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $0.23 | $0.22 | $0.23 | $0.2069 | 1,101,864 | 01-23-2019 |
$ | $0.2397 | $0.2222 | $0.2397 | $0.213 | 1,289,707 | 01-22-2019 |
$ | $0.267 | $0.2381 | $0.267 | $0.2311 | 698,197 | 01-21-2019 |
$ | $0.267 | $0.2381 | $0.267 | $0.2311 | 690,440 | 01-18-2019 |
$ | $0.263 | $0.26 | $0.275 | $0.25 | 452,786 | 01-17-2019 |
$ | $0.2666 | $0.264 | $0.27 | $0.25 | 323,804 | 01-16-2019 |
$ | $0.28 | $0.27 | $0.28 | $0.2519 | 623,097 | 01-15-2019 |
$ | $0.27 | $0.2609 | $0.2731 | $0.2506 | 311,797 | 01-14-2019 |
$ | $0.231 | $0.27 | $0.2748 | $0.225 | 571,221 | 01-11-2019 |
$ | $0.24 | $0.2359 | $0.25 | $0.23 | 196,162 | 01-10-2019 |
$ | $0.2488 | $0.242 | $0.26 | $0.2301 | 415,418 | 01-09-2019 |
$ | $0.2609 | $0.237 | $0.2698 | $0.237 | 507,682 | 01-08-2019 |
$ | $0.25 | $0.2604 | $0.28 | $0.24 | 677,546 | 01-07-2019 |
$ | $0.2395 | $0.235 | $0.252 | $0.22 | 648,053 | 01-04-2019 |
$ | $0.24 | $0.226338 | $0.249 | $0.2174 | 646,953 | 01-03-2019 |
$ | $0.205 | $0.241 | $0.25 | $0.1851 | 1,174,124 | 01-02-2019 |
$ | $0.21 | $0.192 | $0.21 | $0.1851 | 463,205 | 01-01-2019 |
$ | $0.21 | $0.195 | $0.21 | $0.1851 | 436,764 | 12-31-2018 |
$ | $0.19 | $0.195 | $0.208 | $0.185 | 352,967 | 12-28-2018 |
$ | $0.2087 | $0.19 | $0.2087 | $0.1831 | 247,309 | 12-27-2018 |
News, Short Squeeze, Breakout and More Instantly...
Apricus Biosciences Inc. Company Name:
APRI Stock Symbol:
NASDAQ Market:
Apricus Biosciences Inc. Website:
Seeking Shareholder Approval for Proposed Merger with Seelos Therapeutics, Inc. SAN DIEGO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, reminds shareholders to vote by...
Company Merger with Seelos Therapeutics, Inc. Expected to Close in Fourth Quarter 2018 Apricus Shareholders Expected to Own ~15% of Estimated $94 Million Combined Company Valuation at Closing SAN DIEGO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a bioph...